GAMIDA CELL LTD's ticker is GMDA and the CUSIP is M47364100. A total of 65 filers reported holding GAMIDA CELL LTD in Q4 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $30,079 | -46.6% | 29,203 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $56,362 | +138.3% | 29,203 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $23,654 | -37.2% | 29,203 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $37,672 | -24.7% | 29,203 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $50,000 | -3.8% | 29,203 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $52,000 | -57.0% | 29,203 | 0.0% | 0.00% | -50.0% |
Q1 2022 | $121,000 | +63.5% | 29,203 | 0.0% | 0.00% | +100.0% |
Q4 2021 | $74,000 | -35.1% | 29,203 | 0.0% | 0.00% | -50.0% |
Q3 2021 | $114,000 | -51.7% | 29,203 | 0.0% | 0.00% | -60.0% |
Q1 2021 | $236,000 | -36.2% | 29,203 | -33.9% | 0.01% | -50.0% |
Q4 2020 | $370,000 | +58.8% | 44,203 | -25.3% | 0.01% | 0.0% |
Q3 2020 | $233,000 | -8.3% | 59,203 | 0.0% | 0.01% | -9.1% |
Q2 2020 | $254,000 | +195.3% | 59,203 | +102.7% | 0.01% | +175.0% |
Q1 2020 | $86,000 | -31.2% | 29,203 | 0.0% | 0.00% | -20.0% |
Q4 2019 | $125,000 | +3.3% | 29,203 | 0.0% | 0.01% | -16.7% |
Q3 2019 | $121,000 | – | 29,203 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 107,000 | $9,985,000 | 2.25% |
Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. | 175,000 | $721,000 | 0.56% |
Rock Springs Capital Management LP | 2,154,300 | $8,940,000 | 0.22% |
Laird Norton Wetherby Trust Company, LLC | 529,103 | $2,195,000 | 0.20% |
Platform Technology Partners | 55,625 | $231,000 | 0.11% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,000,000 | $4,150,000 | 0.10% |
Guild Investment Management, Inc. | 18,000 | $75,000 | 0.08% |
FEDERATED HERMES, INC. | 5,128,300 | $21,282,000 | 0.05% |
MEITAV INVESTMENT HOUSE LTD | 429,352 | $1,782,000 | 0.03% |
1492 Capital Management LLC | 10,000 | $42,000 | 0.02% |